ABN Newswire - neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or Read More
Sunday, November 25, 2007
Micromet, Inc. Reports Third Quarter 2007 Financial Results
Bookmark this post:
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment